Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression

Journal of Hematology and Oncology

Volumn 7, Issue 1, 2014, Pages

  Xu, Tong Peng ^a   Huang, Ming De ^a   Xia, Rui ^a   Liu, Xin Xin ^b   Sun, Ming ^a   Yin, Li ^a   Chen, Wen Ming ^a   Han, Liang ^a   Zhang, Er Bao ^a   Kong, Rong ^a   De, Wei ^a   Shu, Yong Qian ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

FENDRR; Fibronectin1; Gastric cancer; Metastasis; Prognosis

Indexed keywords

FIBRONECTIN; FIBRONECTIN 1; GELATIN; GELATINASE A; GELATINASE B; LONG UNTRANSLATED RNA; MATRIX METALLOPROTEINASE; MESSENGER RNA; UNCLASSIFIED DRUG; FN1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; EPITHELIUM CELL; FENDRR GENE; GASTRIC CANCER CELL LINE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR INVASION; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY; ADENOCARCINOMA; ANIMAL; BIOSYNTHESIS; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MALE; MORTALITY; MOUSE; NUDE MOUSE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STOMACH TUMOR; TUMOR CELL LINE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908508643     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/s13045-014-0063-7     Document Type: Article

References (38)

1. Cancer epidemiology in mainland South-East Asia-past, present and future. MA Moore, P Attasara, T Khuhaprema, TN Le, TH Nguyen, PP Raingsey, S Sriamporn, H Sriplung, P Srivanatanakul, DT Bui, S Wiangnon, T Sobue, Asian Pac J Cancer Prev 2010 11 Suppl 2 67 80 20553069
2. Cancer statistics, 2010. A Jemal, R Siegel, J Xu, E Ward, CA Cancer J Clin 2010 60 277 300 10.3322/caac.20073 20610543
3. Some problems in the surgical treatment of gastric cancer. XN Wang, H Liang, Chin J Cancer 2010 29 369 373 10.5732/cjc.009.10629 20346210
4. Metastasis suppressors alter the signal transduction of cancer cells. PS Steeg, Nat Rev Cancer 2003 3 55 63 10.1038/nrc967 12509767
5. Nature meets nurture: molecular genetics of gastric cancer. AN Milne, F Carneiro, C O'Morain, GJ Offerhaus, Hum Genet 2009 126 615 628 10.1007/s00439-009-0722-x 19657673
6. Transcribed dark matter: meaning or myth? CP Ponting, TG Belgard, Hum Mol Genet 2010 19 162 R168 10.1093/hmg/ddq362 20798109
7. RNA: Genome-wide views of long non-coding RNAs. M Muers, Nat Rev Genet 2011 12 742 10.1038/nrg3088 21989130
8. Evolution and functions of long noncoding RNAs. CP Ponting, PL Oliver, W Reik, Cell 2009 136 629 641 10.1016/j.cell.2009.02.006 19239885
9. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. JL Rinn, M Kertesz, JK Wang, SL Squazzo, X Xu, SA Brugmann, LH Goodnough, JA Helms, PJ Farnham, E Segal, HY Chang, Cell 2007 129 1311 1323 10.1016/j.cell.2007.05.022 17604720
10. Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas. L Pibouin, J Villaudy, D Ferbus, M Muleris, MT Prosperi, Y Remvikos, G Goubin, Cancer Genet Cytogenet 2002 133 55 60 10.1016/S0165-4608(01)00634-3 11890990
11. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. X Fu, L Ravindranath, N Tran, G Petrovics, S Srivastava, DNA Cell Biol 2006 25 135 141 10.1089/dna.2006.25.135 16569192
12. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. GA Calin, CG Liu, M Ferracin, T Hyslop, R Spizzo, C Sevignani, M Fabbri, A Cimmino, EJ Lee, SE Wojcik, M Shimizu, E Tili, S Rossi, C Taccioli, F Pichiorri, X Liu, S Zupo, V Herlea, L Gramantieri, G Lanza, H Alder, L Rassenti, S Volinia, TD Schmittgen, TJ Kipps, M Negrini, CM Croce, Cancer Cell 2007 12 215 229 10.1016/j.ccr.2007.07.027 17785203
13. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. R Lin, S Maeda, C Liu, M Karin, TS Edgington, Oncogene 2007 26 851 858 10.1038/sj.onc.1209846 16878148
14. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. P Qi, X Du, Mod Pathol 2013 26 155 165 10.1038/modpathol.2012.160 22996375
15. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. P Grote, L Wittler, D Hendrix, F Koch, S Wahrisch, A Beisaw, K Macura, G Blass, M Kellis, M Werber, BG Herrmann, Dev Cell 2013 24 206 214 10.1016/j.devcel.2012.12.012 23369715
16. Genome regulation by polycomb and trithorax proteins. B Schuettengruber, D Chourrout, M Vervoort, B Leblanc, G Cavalli, Cell 2007 128 735 745 10.1016/j.cell.2007.02.009 17320510
17. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. AM Khalil, M Guttman, M Huarte, M Garber, A Raj, D Rivea Morales, K Thomas, A Presser, BE Bernstein, A Van Oudenaarden, A Regev, ES Lander, JL Rinn, Proc Natl Acad Sci U S A 2009 106 11667 11672 10.1073/pnas.0904715106 19571010
18. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. RA Gupta, N Shah, KC Wang, J Kim, HM Horlings, DJ Wong, MC Tsai, T Hung, P Argani, JL Rinn, Y Wang, P Brzoska, B Kong, R Li, RB West, MJ van de Vijver, S Sukumar, HY Chang, Nature 2010 464 1071 1076 10.1038/nature08975 20393566
19. Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. J Nilsson, K Helou, A Kovacs, PO Bendahl, G Bjursell, M Ferno, P Carlsson, M Kannius-Janson, Cancer Res 2010 70 2020 2029 10.1158/0008-5472.CAN-09-1677 20145151
20. Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells. SH Chen, CY Lin, LT Lee, GD Chang, PP Lee, CC Hung, WT Kao, PH Tsai, AV Schally, JJ Hwang, MT Lee, Anticancer Res 2010 30 4177 4186 21036738
21. Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways. T Sen, A Dutta, G Maity, A Chatterjee, Biochimie 2010 92 1422 1434 10.1016/j.biochi.2010.07.005 20638438
22. Fibronectin induces MMP2 expression in human prostate cancer cells. A Moroz, FK Delella, LM Lacorte, E Deffune, SL Felisbino, Biochem Biophys Res Commun 2013 430 1319 1321 10.1016/j.bbrc.2012.12.031 23261429
23. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. K Tano, R Mizuno, T Okada, R Rakwal, J Shibato, Y Masuo, K Ijiri, N Akimitsu, FEBS Lett 2010 584 4575 4580 10.1016/j.febslet.2010.10.008 20937273
24. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. V Srikantan, Z Zou, G Petrovics, L Xu, M Augustus, L Davis, JR Livezey, T Connell, IA Sesterhenn, K Yoshino, GS Buzard, FK Mostofi, DG McLeod, JW Moul, S Srivastava, Proc Natl Acad Sci U S A 2000 97 12216 12221 10.1073/pnas.97.22.12216 11050243
25. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. S Chung, H Nakagawa, M Uemura, L Piao, K Ashikawa, N Hosono, R Takata, S Akamatsu, T Kawaguchi, T Morizono, T Tsunoda, Y Daigo, K Matsuda, N Kamatani, Y Nakamura, M Kubo, Cancer Sci 2011 102 245 252 10.1111/j.1349-7006.2010.01737.x 20874843
26. Identifying tumor suppressor genes in human colorectal cancer. EJ Stanbridge, Science 1990 247 12 13 10.1126/science.2403692 2403692
27. Epigenetic modifications in cancer. R Kanwal, S Gupta, Clin Genet 2012 81 303 311 10.1111/j.1399-0004.2011.01809.x 22082348
28. Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma. L Benetatos, A Dasoula, E Hatzimichael, I Georgiou, M Syrrou, KL Bourantas, Clin Lymphoma Myeloma 2008 8 171 175 10.3816/CLM.2008.n.021 18650181
29. Fibronectin at a glance. R Pankov, KM Yamada, J Cell Sci 2002 115 3861 3863 10.1242/jcs.00059 12244123
30. Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling. JD Ritzenthaler, S Han, J Roman, Mol Biosyst 2008 4 1160 1169 10.1039/b800533h 19396378
31. miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. F Wang, G Song, M Liu, X Li, H Tang, FEBS Lett 2011 585 3263 3269 10.1016/j.febslet.2011.08.052 21924268
32. Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model. S Sengupta, S Nandi, ES Hindi, DA Wainwright, Y Han, MS Lesniak, Neoplasia 2010 12 837 847 20927322
33. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. QZ Dong, Y Wang, ZP Tang, L Fu, QC Li, ED Wang, EH Wang, Am J Pathol 2013 182 954 964 10.1016/j.ajpath.2012.11.019 23306155
34. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. A Katayama, N Bandoh, K Kishibe, M Takahara, T Ogino, S Nonaka, Y Harabuchi, Clin Cancer Res 2004 10 634 640 10.1158/1078-0432.CCR-0864-02 14760086
35. Pivotal role of reduced let-7 g expression in breast cancer invasion and metastasis. P Qian, Z Zuo, Z Wu, X Meng, G Li, Z Wu, W Zhang, S Tan, V Pandey, Y Yao, P Wang, L Zhao, J Wang, Q Wu, E Song, PE Lobie, Z Yin, T Zhu, Cancer Res 2011 71 6463 6474 10.1158/0008-5472.CAN-11-1322 21868760
36. Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis. M Menshikov, E Elizarova, K Plakida, A Timofeeva, G Khaspekov, R Beabealashvilli, A Bobik, V Tkachuk, Biochem J 2002 367 833 839 10.1042/BJ20020663 12117412
37. Animal research: reporting in vivo experiments: the ARRIVE guidelines. C Kilkenny, W Browne, IC Cuthill, M Emerson, DG Altman, NCRRGW Group, D Altman, D Balding, I Cuthill, C Dunn, M Emerson, S Hurtley, I McGrath, C Stanford, J Gene Med 2010 12 561 563 10.1002/jgm.1473 20607692
38. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1). M Sun, XH Liu, JH Li, JS Yang, EB Zhang, DD Yin, ZL Liu, J Zhou, Y Ding, SQ Li, ZX Wang, XF Cao, W De, Mol Cancer Ther 2012 11 842 852 10.1158/1535-7163.MCT-11-1015 22343731